| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |